Veracyte

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Veracyte and other ETFs, options, and stocks.

About VCYT

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. 

CEO
Marc A. Stapley
CEOMarc A. Stapley
Employees
815
Employees815
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2006
Founded2006
Employees
815
Employees815

VCYT Key Statistics

Market cap
3.39B
Market cap3.39B
Price-Earnings ratio
-302.98
Price-Earnings ratio-302.98
Dividend yield
Dividend yield
Average volume
526.52K
Average volume526.52K
High today
$43.95
High today$43.95
Low today
$41.80
Low today$41.80
Open price
$42.49
Open price$42.49
Volume
625.74K
Volume625.74K
52 Week high
$46.00
52 Week high$46.00
52 Week low
$18.61
52 Week low$18.61

VCYT News

Simply Wall St 12h
Veracyte, Inc.'s Intrinsic Value Is Potentially 50% Above Its Share Price

Key Insights Veracyte's estimated fair value is US$65.48 based on 2 Stage Free Cash Flow to Equity Veracyte is estimated to be 33% undervalued based on curren...

Veracyte, Inc.'s Intrinsic Value Is Potentially 50% Above Its Share Price

Analyst ratings

75%

of 12 ratings
Buy
75%
Hold
16.7%
Sell
8.3%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.